The Lupus Nephritis market has shown significant potential, reaching a value of 1.9 billion USD in 2022. Analysts predict a steady growth trajectory with a compound annual growth rate (CAGR) of 6.8%. This positive outlook suggests the market could reach a staggering 3.32 billion USD by 2029, indicating a growing demand for diagnosis, treatment, and management of this chronic kidney condition....